← Back to Search

Capecitabine + Radiotherapy for Breast Cancer

Phase 1
Waitlist Available
Led By Bapsi Chakravarthy, MD
Research Sponsored by A Bapsi Chakravarthy, MD
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 7 months
Awards & highlights

Study Summary

This trial is testing whether a combination of capecitabine and radiotherapy is effective in treating breast cancer that has not responded to other treatments.

Eligible Conditions
  • Triple Negative Breast Cancer
  • Breast Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 7 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 7 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage of patients who complete concurrent capecitabine-radiotherapy
Secondary outcome measures
Assess tolerability
Characterize radiation dermatitis secondary to concurrent capecitabine-radiotherapy
Completion of exploratory assessments
+2 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Concurrent Adjuvant Capecitabine and RadiotherapyExperimental Treatment2 Interventions
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Capecitabine
2013
Completed Phase 3
~3420
Radiotherapy
2017
Completed Phase 3
~2610

Find a Location

Who is running the clinical trial?

A Bapsi Chakravarthy, MDLead Sponsor
Bapsi Chakravarthy, MDPrincipal Investigator - Vanderbilt Medical Center
Vanderbilt-Ingram Cancer Center

Media Library

Radiotherapy Clinical Trial Eligibility Overview. Trial Name: NCT03958721 — Phase 1
Breast Cancer Research Study Groups: Concurrent Adjuvant Capecitabine and Radiotherapy
Breast Cancer Clinical Trial 2023: Radiotherapy Highlights & Side Effects. Trial Name: NCT03958721 — Phase 1
Radiotherapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT03958721 — Phase 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To what extent is Capecitabine commonly employed to treat medical conditions?

"Capecitabine is an effective treatment for a range of malignant neoplasms, including pancreatic endocrine carcinoma and colorectal carcinoma."

Answered by AI

What prior research has been conducted on the efficacy of Capecitabine?

"Currently, 335 clinical trials researching the effects of Capecitabine are actively running with 126 in Phase 3. Most of these experiments originate from Westmead, New South Wales; although there exists a multitude of other research sites spanning 12857 different locations."

Answered by AI

How many participants have been enrolled in the trial thus far?

"Unfortunately, this medical trial is not currently accepting participants. Although the first posting was on July 18th 2019 and it has been updated as recently September 12th 2022, there are no available spots for enrolment. However, 2287 trials related to resistant breast cancer and 335 studies concerning Capecitabine have opened recruitment periods."

Answered by AI

Is it possible to join this clinical experiment at present?

"Although the clinical trial was initially posted on July 18th 2019, per research found on clinicaltrials.gov this study has concluded recruitment and is not searching for new participants at present; however, 2,622 other medical studies are currently open for enrolment."

Answered by AI

Has the FDA accredited Capecitabine for use?

"Capecitabine had limited clinical data to support its safety, thus receiving a score of 1."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Capecitabine and Radiotherapy in the Adjuvant Treatment of Resistant Breast Cancer
A Bapsi Chakravarthy, MD 2019. "Capecitabine and Radiotherapy in the Adjuvant Treatment of Resistant Breast Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03958721.
~3 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top